CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
Monthly Archives: November 2014
Dentists’ Knowledge and Opinions of Oral-Systemic Disease Relationships: Relevance to Patient Care and Education
David W. Paquette, DMD, MPH, DMSc; Kathryn P. Bell, RDH, MS; Ceib Phillips, MPH, PhD; Steven Offenbacher, DDS, PhD, MMSc; Rebecca S. Wilder, RDH, MS
PeriRx, LLC Covering All Bases During Its Greater New York Dental Meeting Debut
The Company’s Launch of Its SaliMark™ OSCC Salivary Test for Oral Cancer Includes Free CE Course, Free Industry Reception, and Free Test Kit
BROOMALL, PA–(Marketwired – Nov 21, 2014) – PeriRx, LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology, will be making its national debut at booth #1506 during the Greater New York Dental Meeting from Sunday, November 30th to Wednesday, December 3rd at the Jacob K. Javits Convention Center in New York City. [Read more…]
Salivary Diagnostics for Oral Cancer Risk Assessment
Neil Gottehrer, DDS; Jack Martin, MD